In addition to HNSCC, we analyzed the expression of ENDOU in other cancer types, as shown in Figure 6A, decreased expression was also observed in bladder cancer (BLCA), breast cancer (BRCA), liver cancer (LIHC) and other cancer samples, indicating a universal role of ENDOU in cancer. Here, ENDOU is linked to breast carcinoma.